Table of Contents

Electroporation-Based Gene Therapy: Recent Evolution in the Mechanism Description and Technology Developments.- Electropermeabilization of the Cell Membrane.- The Impact of Non-Electrical Factors on Electrical Gene Transfer.- Electroporation Formulation for Cell Therapy.- Short-Fragment DNA-Mediated in Vivo DNA Electroporation Delivery.- Gold Nanoparticle-Enhanced Electroporation for Leukemia Cell Transfection.- SiRNA Delivery via Electropulsation: A Review of the Basic Processes.- Continuous Cell Electroporation for Efficient DNA and siRNA Delivery Based on Laminar Microfluidic Chips.- Electroporation of siRNA into Mouse Bone Marrow-Derived Macrophages and Dendritic Cells.- Direct Imaging of siRNA Electrotransfer at the Single Cell Level.- Electroporation-Mediated siRNA Delivery into Tumors.- Substrate-Mediated, High Efficiency siRNA Electroporation.- Intradermal Electroporation of RNA.- Delivery of DNA into the Central Nervous System via Electroporation.- DNA Delivery in Adult Mouse Eyes: An Update with Corneal Outcomes.- Delivery of Plasmid DNA into Developing Rat Teeth by Electroporation.- Electroporation-Mediated Gene Delivery to the Lungs.- Electroporation-Mediated Delivery of Genes in Rodent Models of Lung Contusion.- In Vivo Electroporation-Mediated Gene Delivery to the Beating Heart.- Managing Local Swelling Following Intratumoral Electro-Chemo-Gene Therapy.- Gene Electrotransfer in Clinical Trials.- Electrochemotherapy in Veterinary Oncology: From Rescue to First-line Therapy.- Low Energy DC Current Ablation in a Mouse Tumor Model.- Evolution of Electroporated DNA Vaccines.- Clinical Development of Intramuscular Electroporation: Providing a “Boost” for DNA Vaccines.- Electroporation-Mediated Administration of Candidate DNA Vaccines against HIV-1.- Electroporation-Mediated Intradermal Delivery of DNA Vaccines in Nonhuman Primates.- Intramuscular DNA Vaccination Protocols Mediated by Electric Fields Pieranna.- DNA Electroporation ofMulti-Agent Vaccines Conferring Protection Against Select Agent Challenge—TriGrid Delivery System.- Gene-Based Vaccination and Screening Methods to Develop Monoclonal Antibodies.